Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies.

Chan ASH, Kangas TO, Qiu X, Uhlik MT, Fulton RB, Ottoson NR, Gorden KB, Yokoyama Y, Danielson ME, Jevne TM, Michel KS, Graff JR, Bose N.

Open source

DOI: 10.3389/fonc.2022.869078
Published: 2022-05-26
Container: Front Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2022.869078,
  title = {Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies.},
  author = {Chan ASH and  Kangas TO and  Qiu X and  Uhlik MT and  Fulton RB and  Ottoson NR and  Gorden KB and  Yokoyama Y and  Danielson ME and  Jevne TM and  Michel KS and  Graff JR and  Bose N.},
  year = {2022},
  journal = {Front Oncol},
  doi = {10.3389/fonc.2022.869078},
  url = {https://doi.org/10.3389/fonc.2022.869078}
}

RIS

TY  - JOUR
TI  - Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies.
AU  - Chan ASH
AU  -  Kangas TO
AU  -  Qiu X
AU  -  Uhlik MT
AU  -  Fulton RB
AU  -  Ottoson NR
AU  -  Gorden KB
AU  -  Yokoyama Y
AU  -  Danielson ME
AU  -  Jevne TM
AU  -  Michel KS
AU  -  Graff JR
AU  -  Bose N.
PY  - 2022
JO  - Front Oncol
DO  - 10.3389/fonc.2022.869078
UR  - https://doi.org/10.3389/fonc.2022.869078
ER  -

APA

ASH, C., TO, K., X, Q., MT, U., RB, F., NR, O., KB, G., Y, Y., ME, D., TM, J., KS, M., JR, G., & N., B. (2022). Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies.. Front Oncol. https://doi.org/10.3389/fonc.2022.869078

Source records

europe-pmc · retrieved 2026-09-26T20:20:52.009Z
doaj · retrieved 2026-09-26T20:20:52.008Z